Back

Efficacy and safety results of endovascular baroreflex amplification (EBA) for resistant hypertension (CALM-FIM studies): a safety and proof-of-principle cohort study.

27 August 2017 (16:48 - 17:06)
Organised by:
Congress Presentation Part of: Device-based therapy for hypertension - Where next? Devices / interventions ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Wilko Spiering

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
State of the Art: device-based therapy for hypertension
Professor M. Lobo (London, GB)
Slides Video
Presentation thumbnail
Sham or no-sham control in trials of renal denervation for treatment resistant hypertension: a systematic meta-analysis
Doctor F. Fadl El Mula (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Validating renal nerve stimulation-induced blood pressure changes as a predictor of clinical response to renal sympathetic denervation
Doctor M. de Jong (Zwolle, NL)
Abstract
Presentation thumbnail
Designing trials for devices in hypertension - What have we learned?
Professor F. Mahfoud (Basel, CH)
Slides Video

Access the full session

Session thumbnail
Device-based therapy for hypertension - Where next?

The Event

Event poster

ESC Congress 2017

27 August 2017 16:48 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources